Last update Nov. 15, 2022
Very Low Risk
It is a recombinant human platelet-derived growth factor which is indicated for treatment of diabetic foot. It is applied topically.
At the date of the last update, we found no published data on its excretion in breast milk.
Systemic absorption through skin lesion is not significant (Aizpurua 2004, Balfour 1999). Its high molecular weight and minimal systemic absorption makes it unlikely that it will pass into milk in significant amounts.
Due to its protein nature it would be digested and inactivated in the gastrointestinal tract. This low oral bioavailability minimizes the passage into plasma of the infant from ingested breast milk.
It is advisable to wash hands thoroughly and avoid applying it on the breast.
We do not have alternatives for Becaplermin since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2012 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM